Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease. (2017)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/nm.4307
PubMed Identifier: 28368383
Publication URI: http://europepmc.org/abstract/MED/28368383
Type: Journal Article/Review
Volume: 23
Parent Publication: Nature medicine
Issue: 5
ISSN: 1078-8956